For a quarter-century, DCR has played a pivotal role in advancing kidney care driving access to new therapies, improving clinical outcomes and shaping the future of nephrology through rigorous research and clinical trials
However, the only reliable safety data on GSH are of sporadic use during chemotherapy cycles, for a few weeks at most
If you cannot keep fluids down or these signs do not improve, contact your doctor or pharmacist
**Reduction in Fatty Liver Disease**: Weight loss with these medications often leads to decreased liver fat, potentially improving or reversing non-alcoholic fatty liver disease[3]
660 Interestingly, DMPS has also been identified as a zinc chelator and has been found to effectively antagonize Zn 2+ -dependent snake venom metalloproteinases in vitro
This rapid clearance is one of its key safety features in a research context